PeaceHealth and De Facto Exclusive Dealing, Part III
Josh’s thoughtful response (Bitchslap? Nah.) to my post criticizing the Ninth Circuit’s recent Masimo decision raises a number of important matters. I started to just . . .
PeaceHealth and De Facto Exclusive Dealing, Part III
Gelbach, Helland and Klick on Single Firm, Single Event Studies
Larry Ribstein points to the new paper from Gelbach, Helland and Klick on Valid Inference in Single Firm, Single Event Studies. This is an important . . .
Hayek and the Fall of the Wall
As we reflect back on the remarkable events of twenty years ago, and as we witness more and more centralized economic planning in our own . . .
Should PeaceHealth Apply to De Facto Exclusive Dealing Claims?
Thom answers this question in the affirmative in his excellent post about the Ninth Circuit’s analysis in Masimo and is disappointed that the Ninth Circuit . . .
Oracle is nonplussed; the DOJ is . . . plussed?
The European Commission has issued a Statement of Objections in response to Oracle’s proposed acquisition of Sun. The deal had already cleared the DOJ’s review. . . .
As New York goes, so goes the FTC?
The New York Times is reporting that New York’s attorney general, Andrew Cuomo, has filed an antitrust suit against Intel. According to the report… Read . . .
The CFPA’s Effect on Consumer Credit and A Wager Proposal for Professor Levitin
Professor Adam Levitin is not impressed by our prediction of the effect on consumer credit of the CFPA. Readers might recall that, using estimates from . . .
PeaceHealth Should Apply Even When a Bundled Discount Results in “De Facto” Exclusive Dealing
The Ninth Circuit, whose PeaceHealth decision moved the law on bundled discounting in the right direction, recently issued another decision on bundled discounts. That decision, . . .
Of Broken Windows and Broken Policy
Today the Obama administration announced with great pride that its economic stimulus plan created or saved about 650,000 jobs. “Thank goodness!” reads the subtext. If . . .